readthroughSign in
CompanyARTVNasdaqSan Diego, CA

Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics develops AlloNK, an allogeneic natural killer cell therapy for autoimmune diseases including refractory rheumatoid arthritis, Sjögren disease, systemic sclerosis, and myositis.

424B3Nov 12Latest SEC filing
Nov 9Latest story